Promising treatments are coming: a message to lymphoma and CLL patients
The world is changing and in the next decade cancer treatment is sure to be completely changed. Speaking from the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, George Follows, BMBCh, PhD, FRCP, FRCPath, of Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, gives a positive message to lymphoma and chronic lymphocytic leukemia (CLL) patients. Dr Follows emphasizes the exciting time that this is for research, with novel drugs moving through to licensing and the clinic.
Related videos
0:48
The need for increased care and support for patients with high-risk multiple myeloma
Cynthia Chmielewski
5:44
What is the best therapy for a young patient with relapsed/refractory CLL?
Jacqueline Barrientos
1:21
METUP UK: advocacy for breast cancer patients
Beth Roberts
1:32
Patient advocacy: an essential role
Catherine Bouvier
1:34
Patient support NETworks: the NeuroEndocrine Tumor (NET) Patient Foundation
Catherine Bouvier
